等待开盘 02-17 09:30:00 美东时间
0.000
0.00%
vTv Therapeutics Inc. announced that its management team will participate in H.C. Wainwright's "HCW@Home" virtual event on June 12, 2025. The session will feature a fireside chat with key executives discussing the company's development of cadisegliatin, a potential first-in-class oral therapy for type 1 diabetes currently in Phase 3 trials.
2025-06-11 12:00